This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: University of California, Prelude Corporation. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Thea D Tlsty: Innovator in Cancer Research
Introduction
Thea D Tlsty is a prominent inventor based in San Francisco, CA, known for her significant contributions to cancer research. With a focus on developing innovative detection methods and cellular compositions, she has made strides in understanding and diagnosing pre-cancerous conditions.
Latest Patents
Thea D Tlsty holds 3 patents that showcase her groundbreaking work. Her first patent, titled "Cancer biomarkers and methods of use thereof," provides detection methods for identifying a pre-cancerous epithelial cell signature. This invention includes reagents that enhance the detection process, proving useful in various imaging, diagnostic, prognostic, and patient monitoring methods. Her second patent, "Somatic cells with innate potential for pluripotency," focuses on compositions of somatic cells that can differentiate into functional derivatives of the major germ layers. This patent also includes methods and kits for identifying and isolating these somatic cells for research or therapeutic purposes.
Career Highlights
Throughout her career, Thea D Tlsty has worked with esteemed institutions, including the University of California and Prelude Corporation. Her work has significantly impacted the field of cancer research, leading to advancements in diagnostic techniques and therapeutic applications.
Collaborations
Thea has collaborated with notable colleagues, including Hal K Berman and Mona L Gauthier, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Thea D Tlsty's contributions to cancer research through her patents and collaborations highlight her role as a leading innovator in the field. Her work continues to pave the way for advancements in cancer detection and treatment.